AHCO — AdaptHealth Corp. stock price, charts and financials

QT36AdaptHealth Corp.

AdaptHealth Corp. (NASDAQ: AHCO) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
5.22
-0.47-8.26%
OverviewShort InterestFilings
AHCOQT36AdaptHealth Corp.·NASDAQ
5.22-8.26%
TA
Loading chart...
Signal & projected range
Analyst consensus risingHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
SSII-1.06%$3.73SIBN+1.24%$18.84BBNX+3.14%$16.40CBLL+2.60%$19.30AVR+0.56%$8.96INMD-0.78%$15.19TCMD-1.22%$29.14BWAY-1.16%$15.32
Snapshot
Index-P/E-EPS (ttm)-0.59Insider Own-Shs Outstand136.05MPerf Week-47.31%
Market Cap774.15MForward P/E45.67EPS next Y0.12Insider Trans4.25%Shs Float86.27MPerf Month-44.00%
Enterprise Value2.80BPEG0.11EPS next Q-Inst Own-Short Float9.29%Perf Quarter-51.49%
Income-228.14MP/S0.26EPS this Y95.93%Inst Trans-Short Ratio5.49Perf Half Y-45.76%
Sales3.01BP/B0.56EPS next Y619.13%ROA-5.26%Short Interest8.01MPerf YTD-42.87%
Book/sh-P/C1.33EPS next 5Y-ROE-15.16%52W High12.32 -57.63%Perf Year-42.23%
Cash/sh-P/FCF7.93EPS past 3/5Y-ROIC-0.24%52W Low5.20 0.35%Perf 3Y-58.07%
Dividend Est.-EV/EBITDA9.64Sales past 3/5Y2.98% 25.17%Gross Margin10.37%Volatility7.58% 4.88%Perf 5Y-74.59%
Dividend TTM-EV/Sales0.93EPS Y/Y TTM-196.72%Oper. Margin-0.31%ATR (14)0.70Perf 10Y-
Dividend Ex-Date-Quick Ratio0.98Sales Y/Y TTM-12.27%Profit Margin-7.58%RSI (14)17.52Recom2.33
Dividend Gr. 3/5Y-Current Ratio1.12EPS Q/Q-SMA20-42.37%Beta1.34Target Price10.29
Payout0.00%Debt/Eq1.50Sales Q/Q41.38%SMA50-42.90%Rel Volume2.85Prev Close5.69
Employees10,900LT Debt/Eq1.20EarningsNov 03SMA200-45.03%Avg Volume1.97MPrice5.22
IPO DateMay 31, 2018Option/ShortYes / YesEPS/Sales Surpr.-580.08% 2.91%Net Debt/EBITDA6.97Volume5,618,513Change-8.26%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-06-26ReiteratedUBSBuy$14 → $10
Aug-06-26ReiteratedRBC CapitalOutperform$15 → $8.00
Aug-05-26ReiteratedRobert W. Baird$15 → $10
Aug-05-26ReiteratedCanaccord GenuityBuy$16 → $10
Aug-05-26ReiteratedTruist SecuritiesBuy$12 → $9.00
Jul-21-26UpgradeJefferiesHold → Buy$11 → $13
Jul-06-26ReiteratedRobert W. Baird$18 → $15
May-11-26ReiteratedRBC CapitalOutperform$13 → $15
May-06-26ReiteratedRobert W. Baird$17 → $18
May-06-26ReiteratedCanaccord GenuityBuy$16
Latest News
Aug-07-26
Aug-07-2604:05PM
AdaptHealth Corp. to Participate in Upcoming Investor Conferencesbusinesswire.com
10:07AM
AHCO Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into AdaptHealth Corp. (AHCO)businesswire.com
Aug-06-26
Aug-06-2611:00AM
Securities Fraud Investigation Into AdaptHealth Corp. (AHCO) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firmbusinesswire.com
10:00AM
AdaptHealth Corp. (AHCO) Shareholders Who Lost Money -- Contact Law Offices of Howard G. Smith About Securities Fraud Investigationgurufocus.com
Aug-05-26
Aug-05-2603:19PM
Securities Fraud Investigation Into AdaptHealth Corp. (AHCO) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruzbusinesswire.com
02:01PM
AdaptHealth Corp. Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into AdaptHealth Corp. (AHCO)prnewswire.com
01:58PM
Truist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $9Benzinga
07:30AM
AdaptHealth: Fixed-Price Contracts Create Too Much Riskseekingalpha.com
Aug-04-26
Aug-04-2601:09PM
AHCO INVESTOR ALERT: Investigation of AdaptHealth Corp. Announced by Holzer & Holzer, LLCglobenewswire.com
11:09AM
AdaptHealth Corp. (AHCO) Q2 2026 Earnings Call Transcriptseekingalpha.com
10:06AM
AdaptHealth Q2 Earnings Call Highlightsmarketbeat.com
07:00AM
AdaptHealth Corp. Announces Second Quarter 2026 Resultsbusinesswire.com
Aug-01-26
Aug-01-2603:41AM
Arrowstreet Capital Limited Partnership Has $10.08 Million Stake in AdaptHealth Corp. $AHCOdefenseworld.net
Jul-29-26
Jul-29-2611:10AM
Cardinal Health (CAH) Stock Looks Pricey Following Its Home Care Deal PushYahoo
Jul-24-26
Jul-24-2604:17PM
3 Small-Cap Stocks That Fall ShortYahoo
Company

AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States. The company specializes in sleep therapy, providing CPAP and bi-PAP devices and support for individuals managing obstructive sleep apnea. It also furnishes essential medical devices and provisions for diabetes treatment, such as continuous glucose monitors and insulin pumps. AdaptHealth supplies HME to patients transitioning from acute care settings, offers in-home oxygen and chronic therapy services, and caters to chronically ill patients with specialized equipment and supplies for wound care, urological, incontinence, ostomy, and nutritional needs. These services are accessible to beneficiaries of Medicare, Medicaid, and various commercial insurance payors. AdaptHealth Corp. is primarily based in Plymouth Meeting, Pennsylvania.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue3,0093,2453,261——————
Cost of Goods Sold Incl. D&A2,6962,6762,580——————
Gross Profit311569681——————
Selling, General and Administrative Excl. Other385382359——————
Research and Development
000——————
Other Operating Expense-63058——————
Operating Income-10186264——————
Interest Expense101106127——————
Unusual Expense
—————————
Non-Operating Income (Expense)-135-96-1——————
Net Income Before Taxes-247-15136——————
Income Taxes-115141——————
Consolidated Net Income-228-7190——————
Net Income From Continuing Operations-235-6695——————
Net Income-228-7190——————
EPS (Recurring)-1.68-0.520.62——————
EPS (Basic, Before Extraordinaries)-1.68-0.520.62——————
EPS (Diluted)-1.68-0.520.61——————
EBITDA290504628——————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio——15.61——————
Price To Sales Ratio0.240.410.39——————
Gross Margin10.3417.5320.88——————
Operating Margin-0.335.738.10——————
Net Margin-7.58-2.192.76——————
Shares Outstanding136135134——————
Market Capitalization7101,3451,276——————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$14.53$12.03$9.54$7.04$4.54● Close Price0.00M12.18M24.35M36.53M48.70MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Schuster III Russell E.Chief Commercial OfficerJul 01 '26Sale10.4411,275117,711125,263Jul 06
Schuster III Russell E.Chief Commercial OfficerJun 01 '26Sale10.0611,275113,427136,538Jun 03
OEP VII GP, L.L.C.10% OwnerMar 20 '26Buy9.91447,1004,431,70016,312,698Mar 30
OEP VII GP, L.L.C.10% OwnerMar 19 '26Buy9.947277,22815,865,598Mar 30
OEP VII GP, L.L.C.10% OwnerMar 12 '26Buy9.73689,3366,707,17015,864,871Mar 30
OEP VII GP, L.L.C.10% OwnerMar 11 '26Buy9.73536,8275,222,30715,175,535Mar 30
OEP VII GP, L.L.C.10% OwnerMar 10 '26Buy9.73820,5287,982,67114,638,708Mar 30
CASHIN RICHARD M JR10% OwnerMar 20 '26Buy9.91447,1004,431,70016,312,698Mar 23
CASHIN RICHARD M JR10% OwnerMar 19 '26Buy9.947277,22815,865,598Mar 23
Prast Albert A.Chief Technology OfficerMar 13 '26Option Exercise4.3889,451391,795532,358Mar 16
CASHIN RICHARD M JR10% OwnerMar 12 '26Buy9.73689,3366,707,17015,864,871Mar 12
CASHIN RICHARD M JR10% OwnerMar 11 '26Buy9.73536,8275,222,30715,175,535Mar 12
CASHIN RICHARD M JR10% OwnerMar 10 '26Buy9.73820,5287,982,67114,638,708Mar 12
WOLF DALE BDirectorFeb 27 '26Buy8.968,00071,680104,235Mar 03
Rew Richard W. IICLO and General CounselFeb 26 '26Buy8.915,00044,550107,097Feb 27
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.